Company Profile

Function Promoting Therapies LLC
Profile last edited on: 3/12/2020      CAGE: 6KT27      UEI: WB7EPYZTRLF3

Business Identifier: Accurate diagnosis of male reproductive disorders
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

130 2nd Avenue Suite 121
Waltham, MA 02451
   (626) 676-2502
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Function Promoting Therapies, LLC, (FPT, LLC) and the firm's in-use (commercialization) arm of FPT, LLC, is organized around providing advanced technologies designed to improve accuracy in the diagnosis and rational management of testosterone replacement therapy for male reproductive disorders. Designated TruT Companion Diagnostics, the firm's approach is to achieve definitive diagnosis and institute rational management of androgen disorders. Based on the fundamental discovery of testosterone partitioning, FTC personnel has developed an accurate free testosterone determination method that with other key elements is enabling a framework for accurate determination of free testosterone values and to make progress towards an understanding of the basis of androgen disorders and other conditions.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $4,187,492
Project Title: Novel Algorithm for Free Testosterone Determination

Key People / Management

  Shalender Bhasin

  Dylan Bulseco -- Chief Commercialization Officer

  Ravi Jasuja -- Chief Scientific Officer

  Brian Lacroix -- Finance and Compliance

  Brian Lawney -- Director of Computational Science

  Sam Mawn-Mahlau -- Corporate counsel

  Shantikumar Nair -- Principal Scientist

  Mikhail Zakharov

Company News

There are no news available.